Extended Remdesivir Infusion for Persistent Coronavirus Disease 2019 Infection.

Mario A MartinezTing-Yi ChenHosoon ChoiMunok HwangDhammika NavarathnaLinhue HaoMichael GaleGregory CamusHector E RamirezChetan Jinadatha

Published in: Open forum infectious diseases (2022)

Persistent severe acute respiratory syndrome coronavirus 2 infection is difficult to treat. Here, we report a case of 5-month persistent coronavirus disease 2019 in an immunocompromised patient who was successfully treated with 30 consecutive days of remdesivir. Prolonged remdesivir infusion with concurrent cycle threshold monitoring might provide a potential solution to cure these patients with difficult-to-treat infections.

Keyphrases

coronavirus disease
respiratory syndrome coronavirus
sars cov
low dose
intensive care unit
radiation therapy
locally advanced
rectal cancer